auto macs (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
97
Structured Review
Miltenyi Biotec
auto macs
Auto Macs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 371 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auto+macs+separation+system/autoMACS+Running+Buffer+-+MACS+Separation+Buffer/pm41671421-296-26-30
Average 97 stars, based on 371 article reviews
Auto Macs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 371 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auto+macs+separation+system/autoMACS+Running+Buffer+-+MACS+Separation+Buffer/pm41671421-296-26-30
Average 97 stars, based on 371 article reviews
auto macs - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Isolation:Article Title: The Role of Toll-like Receptors (TLRs) in Bacteria-induced Maturation of Murine Dendritic Cells (DCs) Article Snippet: .. Allogeneic CD41 T cells were isolated employing CD4 microbeads (Milteny Biotech, Bergisch-Gladbach, Germany) and an Article Title: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Article Snippet: Pieter Sonneveld and Hartmut Goldschmidt Mathias Haenel, Hans G. Derigs, Marc S. Raab, Anthony D. Ho, Helgi van de Velde, Dirk Hose, Walter Lindemann, Ingo G. H. Schmidt-Wolf, Norma Peter, Christian Teschendorf, Hans Martin, Dührsen, Hans Salwender, Igor W. Blau, Katja Weisel, Michael Pfreundschuh, Christof Scheid, Ulrich Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, deletion 17p transplantation improves outcome in multiple myeloma patients with Administration of bortezomib before and after autologous stem cell Clinical Proteomics:Article Title: Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study. Article Snippet: .. Plasma cell separation by MACS using anti-CD138 immuno-beads and an Article Title: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Article Snippet: Pieter Sonneveld and Hartmut Goldschmidt Mathias Haenel, Hans G. Derigs, Marc S. Raab, Anthony D. Ho, Helgi van de Velde, Dirk Hose, Walter Lindemann, Ingo G. H. Schmidt-Wolf, Norma Peter, Christian Teschendorf, Hans Martin, Dührsen, Hans Salwender, Igor W. Blau, Katja Weisel, Michael Pfreundschuh, Christof Scheid, Ulrich Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, deletion 17p transplantation improves outcome in multiple myeloma patients with Administration of bortezomib before and after autologous stem cell Magnetic Cell Separation:Article Title: Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study. Article Snippet: .. Plasma cell separation by MACS using anti-CD138 immuno-beads and an Article Title: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Article Snippet: Pieter Sonneveld and Hartmut Goldschmidt Mathias Haenel, Hans G. Derigs, Marc S. Raab, Anthony D. Ho, Helgi van de Velde, Dirk Hose, Walter Lindemann, Ingo G. H. Schmidt-Wolf, Norma Peter, Christian Teschendorf, Hans Martin, Dührsen, Hans Salwender, Igor W. Blau, Katja Weisel, Michael Pfreundschuh, Christof Scheid, Ulrich Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, deletion 17p transplantation improves outcome in multiple myeloma patients with Administration of bortezomib before and after autologous stem cell |